Đang chuẩn bị liên kết để tải về tài liệu:
Heterogeneity of PD-L1 expression in primary tumors and paired lymph node metastases of triple negative breast cancer

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ

Programmed cell death ligand 1 (PD-L1) is a potential predictive biomarker of the response to antiPD-L1/anti- programmed cell death 1 (PD-1) therapy in multiple cancers, including triple negative breast cancer(TNBC). | Heterogeneity of PD-L1 expression in primary tumors and paired lymph node metastases of triple negative breast cancer

TÀI LIỆU LIÊN QUAN

Ebook Cellular heterogeneity: Methods and protocols

Intratumor heterogeneity index of breast carcinomas based on DNA methylation profiles

A heterogeneity analysis on SPV investment of Chinese banks

Ebook Precision crop protection - The challenge and use of heterogeneity

Structural and dynamics heterogeneity in sodium silicate liquid

A comparison of reference-based algorithms for correcting cell-type heterogeneity in Epigenome-Wide Association Studies

Etiology-associated heterogeneity in acute respiratory distress syndrome: A retrospective cohort study

CRISPR-Cas9 identifies growth-related subtypes of glioblastoma with therapeutical significance through cell line knockdown

FIRE IN CALIFORNIA’S ECOSYSTEMS

Ecosystem Function in Heterogeneous Landscapes